@FierceBiotech: Medidata snags biz from rival Oracle in record Q1. Article | Follow @FierceBiotech
@JohnCFierce: AstraZeneca says so long to half a billion dollars; formally ends Targacept depression deal. Story | Follow @JohnCFierce
@RyanMFierce: Mersana has snagged $4M more for work on next-gen ADCs targeting cancer. More | Follow @RyanMFierce
@MarkHFierce: Could the device tax hurt Minnesota's lead status as a med device employer? Trouble has already come, it seems. Article | Follow @MarkHFierce
> Dara BioSciences has raised $10.25 million through a stock sale. The company plans to use the money to launch two new cancer drugs. Story
> Cambridge, MA-based Mersana Therapeutics has filed SEC documents which show it raised an additional $4 million. Filing
> Shares of Amarin ($AMRN) jumped on Monday as analysts at Citi released new estimates showing that AMR101 could hit $2.6 billion in peak sales--provided the company strikes a partnership deal. Story
> Salix Pharma says that the FDA has extended its review of crofelemer by 90 days. The drug is designed to treat HIV-related diarrhea. Story
Pharma News
@FiercePharma: Our latest and greatest ranking of highest-paid CEOs in pharma. Some you'd expect, some you wouldn't. Report | Follow @FiercePharma
> Abbott tries to throw up roadblock to Humira biosim. Story
> Avastin, Lucentis equally effective at improving vision, big study finds. More
Medical Devices News
@FierceMedDev: Scientific American: Four Medical Implants that Escaped FDA Scrutiny. News | Follow @FierceMedDev
> St. Jude, Edwards among those named as potential J&J M&A targets. Article
> Breast cancer risk test inches closer to reality. Story
> Hospira sees profits fall 73%. Item
> St. Jude touts safety of leads with Optim insulation. News
Biotech Research News
> Stay calm, folks: Highly anxious mice developed more aggressive cancer. Story
> U-M registers second stem cell line as research fight continues. News
> U.K. scientists map structure of crucial obesity receptor region. Article
> Cleveland Clinic researcher seeks funds to advance breast cancer vaccine into human trials. More
> Potential Alzheimer's treatment disrupts amyloid protein formation. Item
Pharma Manufacturing News
> BASF moves some production from Illinois to Germany. News
> Claris claims it has passed FDA plant inspection. Story
> Haemonetics, Pall ink $550M deal. Article
And Finally… A new study concludes that even as children make up the majority of patients in a wide range of diseases, they are rarely tested in clinical studies. Report